SUMOylation in the control of cholesterol homeostasis

Abstract

SUMOylation—protein modification by the small ubiquitin-related modifier (SUMO)—affects several cellular processes by modulating the activity, stability, interactions or subcellular localization of a variety of substrates. SUMO modification is involved in most cellular processes required for the maintenance of metabolic homeostasis. Cholesterol is one of the main lipids required to preserve the correct cellular function, contributing to the composition of the plasma membrane and participating in transmembrane receptor signalling. Besides these functions, cholesterol is required for the synthesis of steroid hormones, bile acids, oxysterols and vitamin D. Cholesterol levels need to be tightly regulated: in excess, it is toxic to the cell, and the disruption of its homeostasis is associated with various disorders like atherosclerosis and cardiovascular diseases. This review focuses on the role of SUMO in the regulation of proteins involved in the metabolism of cholesterol.

The First Pituitary Proteome Landscape From Matched Anterior and Posterior Lobes for a Better Understanding of the Pituitary Gland

“…3 and 4 ). SUMOylation is required for various post-translational modifications of proteins such as TSHβ, PTTG1 (pituitary tumor–transforming 1), histone acetylation, and plays a crucial role in nuclear program modification, development, cholesterol homeostasis, and adaptation to stressful conditions ( 33 , 34 , 35 ). Sujie et al.…”

SUMOylation of PUM2 promotes the vasculogenic mimicry of glioma cells via regulating CEBPD

“…SUMOylation regulates protein function by covalently binding to lysine residues in the target protein, which is similar to ubiquitination 15,39 . It was previously thought that SUMOylation is involved in the regulation of various intracellular protein biological functions, such as regulating the activity of transcription factors, 40 controlling protein phase separation, 41 mediating the nuclear translocation of proteins or the formation of subnuclear structures, 42,43 and increasing protein stability 44 . However, in the study of APL, it is found that arsenic‐induced PML SUMOylation triggers polyubiquitination at Lys 48 and proteasome‐dependent degradation 45 .…”

Protein posttranslational modifications in health and diseases: Functions, regulatory mechanisms, and therapeutic implications

“…These receptors are potential therapeutic targets for lipid metabolism disorders. 1018 Studies have found that insufficient insulin secretion or output disorders will eventually lead to diabetes. The E3 SUMO ligase PIASy can inhibit insulin secretion by reducing the interaction between ICA512 and STAT5 through SUMOylation of ICA512.…”